Health economics study of ultra-short wave therapy adjuvant to drug therapy for acute pharyngitis
10.3969/j.issn.1671-332X.2025.10.017
- VernacularTitle:超短波辅助药物治疗急性咽喉炎的卫生经济学研究
- Author:
Huanjin ZHANG
1
;
Shuxiu PENG
1
;
Binbin ZHU
1
;
Yueqing LIN
1
;
Wei MENG
1
;
Yingyue CHEN
1
;
Xiaoyun WANG
1
Author Information
1. 广东省工伤康复医院 广东 广州 510440
- Publication Type:Journal Article
- Keywords:
Ultra-short wave;
Acute pharyngitis;
Clinical efficacy;
Health economics
- From:
Modern Hospital
2025;25(10):1547-1549,1568
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the health economics of ultra-short wave therapy adjuvant to drug therapy for acute pharyngitis,and to provide a more cost-effective treatment option for clinical management.Methods Seventy patients with acute pharyngitis were randomly divided into a control group(35 cases)and an ultra-short wave group(35 cases).The control group received conventional drug therapy,while the ultra-short wave group received ultra-short wave therapy in addition to conventional drug therapy.The cure rate,treatment duration,direct costs,indirect costs,and total costs were compared between the two groups for clinical efficacy and health economics analysis.Results The cure rate in the ultra-short wave group was significantly higher than that in the control group(P=0.008),while the total treatment cost and treatment duration were significantly re-duced.To achieve the same therapeutic effect,the ultra-short wave group required 129.73 yuan less than the control group.Conclusion Ultra-short wave therapy adjuvant to conventional drug treatment for acute pharyngitis can more rapidly alleviate symptoms,reduce indirect costs due to work absence,without significantly increasing treatment expenses.It is a safe,effective,and economical therapy with higher therapeutic value compared to drug therapy alone,and is worthy of widespread promotion.
